US Stock Fluctuation: Legend Biotech surged on October 14th due to CARVYKTI sales
Bitget异动解读2026/10/14 17:35Legend Biotech October 14 Surge Analysis
Keywords: CARVYKTI sales
For the quarter ended September 30, 2026, the preliminary net trade sales of CARVYKTI, a collaboration between Legend Biotech and Janssen, amounted to approximately $710 million; this data is based on information provided by Janssen and has not been independently verified by either party.
(Disclaimer: This content is a summary generated by AI technology from publicly available information and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nvidia-backed Iambic completes US IPO, raising $150 millions
Delayed Again! Rocket Lab (RKLB.US) Neutron rocket's maiden flight postponed to 2027, after-hours stock price plunged more than 9%
Rocket Lab Corp. has once again postponed the maiden flight of its new heavy-lift rocket, Neutron, delaying its first launch to 2027.
He Xiaopeng promotes XPeng AI Project at the 2026 Paris Auto Summit
Crypto prices
More
